Bristol-Myers to spend $250 mln to expand biologics facility

April 11 Thu Apr 11, 2013 10:30am EDT

April 11 (Reuters) - Bristol-Myers Squibb Co on Thursday said it plans to spend $250 million to expand its Devens, Massachusetts, facility that makes large-scale biologic drugs.

The company said the expansion will introduce biologics development and clinical trial manufacturing capabilities to the site and add about 350 employees to the Devens workforce over time.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.